APOE and Alzheimer disease: We find it a notable observation that hyperphosphorylated forms of tau, which are considered pathogenic, bind less efficiently to LRP1 and are internalized less efficiently by LRP1 and that apoE4, an isoform that is linked to early onset AD, is more effective in reducing the capacity of LRP1 to internalize tau.